September 9, 2014 | A team led by the U.K.'s Medicines and Healthcare Products Regulatory Agency (MHRA) and Swiss drug developer Novartis is collaborating on an app that could be used by patients and providers to step up reporting of adverse drug events. The project, web-RADR, will also bring aboard the European Medicines Agency and smaller European regulators, and six additional members of the European Federation of Pharmaceutical Industries and Associations. Over three years, web-RADR will release and analyze preliminary data from both a social media and a mobile platform. In-Pharma Technologist